Yi Liu
Affiliations: | 1994-1998 | Chemistry | Princeton University, Princeton, NJ |
Google:
"Yi Liu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen Y, Zhang S, Li Z, et al. (2023) Discovery of a dual-target inhibitor of CDK7 and HDAC1 that induces apoptosis and inhibits migration in colorectal cancer. Chemmedchem. e202300281 |
| Sun G, Zhang Q, Liu Y, et al. (2022) Role of Phosphatidylinositol 3-Kinase and Its Catalytic Unit PIK3CA in Cervical Cancer: A Mini-Review. Applied Bionics and Biomechanics. 2022: 6904769 |
| Peng Y, Zuo W, Zhou H, et al. (2022) EXPLICIT-Kinase: a gene expression predictor for dissecting the functions of the Arabidopsis kinome. Journal of Integrative Plant Biology |
| Wen J, Hu H, Chen M, et al. (2021) Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review. Journal of Immunology Research. 2021: 2324400 |
| Liu Y, Fu L, Wu J, et al. (2021) Transcriptional cyclin-dependent kinases: Potential drug targets in cancer therapy. European Journal of Medicinal Chemistry. 229: 114056 |
| Kenchappa RS, Liu Y, Argenziano MG, et al. (2021) Protein kinase C and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities. Cell Reports. 37: 110054 |
| Finlay MRV, Barton P, Bickerton S, et al. (2021) Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor to Overcome C797S-Mediated Resistance. Journal of Medicinal Chemistry |
| Liu J, Ma J, Liu Y, et al. (2020) PROTACs: a novel strategy for cancer therapy. Seminars in Cancer Biology |
| Fang E, Wang X, Wang J, et al. (2020) Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression. Theranostics. 10: 1555-1571 |
| Klossowski S, Miao H, Kempinska K, et al. (2019) Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. The Journal of Clinical Investigation |